A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma

BACKGROUND: Recent studies emphasize the role of BRAF as a genetic marker for prediction, prognosis and risk stratification in colorectal cancer. Earlier studies have reported the incidence of BRAF mutations in the range of 5-20% in colorectal carcinomas (CRC) and are predominantly seen in the serra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Siraj, Abdul K, Bu, Rong, Prabhakaran, Sarita, Bavi, Prashant, Beg, Shaham, Al Hazmi, Mohsen, Al-Rasheed, Maha, Alobaisi, Khadija, Al-Dayel, Fouad, AlManea, Hadeel, Al-Sanea, Nasser, Uddin, Shahab, Al-Kuraya, Khawla S
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109832/
https://ncbi.nlm.nih.gov/pubmed/25005754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-168
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars